HEAT DISSIPATION STRUCTURE AND NEUTRON BEAM GENERATING DEVICE USING THE SAME

    公开(公告)号:US20240349418A1

    公开(公告)日:2024-10-17

    申请号:US18319504

    申请日:2023-05-18

    IPC分类号: H05H3/06 A61N5/10

    摘要: A heat dissipation structure includes a housing. The housing has opposing upper and lower surfaces, and a fluid channel between the upper surface and the lower surface. The fluid channel is configured to allow a fluid to pass through, and the fluid channel includes an inlet buffer tank, an outlet buffer tank and a connecting structure. The inlet buffer tank has opposing first inner wall and second inner wall surfaces. The outlet buffer tank has opposing first inner wall and second inner wall surfaces, and the second inner wall surface is closer to the inlet buffer tank than the first inner wall surface. The connecting structure is disposed on the inlet buffer tank and the outlet buffer tank, in which the connecting structure has a first bevel surface and a second bevel surface connected to the upper surface of the housing.

    DEVICE FOR APPLYING ULTRASOUND TO SUPERFICIAL TARGETS

    公开(公告)号:US20240342509A1

    公开(公告)日:2024-10-17

    申请号:US18631128

    申请日:2024-04-10

    IPC分类号: A61N7/00

    摘要: A device for stationary delivery of focused ultrasound therapy to a body surface treatment area of a patient includes a plurality of ultrasound emitters arranged in a flexible array, each emitter of the plurality of emitters having a polygonic geometry and a plurality of edges. At least one edge of each emitter is adjacent to and forms a narrow gap between the at least one edge and an edge of at least one other emitter of the plurality of emitters. Each emitter has an external face and an opposite internal face. The flexible array provides an area of uniform emitter coverage so that uniform ultrasonic waves are applied to the body surface treatment area of the patient when the device is placed onto, so as to conform to, a curvature of the body surface treatment area, and the external face of each emitter is adjacent to the treatment area.

    MONITORING AND CLASSIFICATION OF CARDIAC ARREST RHYTHM

    公开(公告)号:US20240342495A1

    公开(公告)日:2024-10-17

    申请号:US18579604

    申请日:2022-07-13

    IPC分类号: A61N1/39

    CPC分类号: A61N1/39044 A61N1/3993

    摘要: Embodiments comprise an electrocardiograph device for detecting electrical signals of a ventricular fibrillation event in a patient and producing ECG data, a classifier, and a display device. The classifier comprises a memory and a processor, the memory storing a model and one or more parameters of the model. The memory further stores instructions that when executed by the processor the processor to receive the ECG data, and generate a determination indicating whether the ventricular fibrillation event has been caused by heart muscle ischemia based on the model, the parameters of the model. The display device is configured to output the determination, which can also be communicated to follow-on provider systems. The determination can also indicate a predicted coronary perfusion pressure.

    SYSTEMS AND METHODS FOR CARDIAC PACING USING BETA BLOCKERS

    公开(公告)号:US20240342487A1

    公开(公告)日:2024-10-17

    申请号:US18682569

    申请日:2022-08-24

    申请人: BaroPace, Inc.

    发明人: Michael BURNAM

    摘要: Techniques and systems disclosed herein are directed to determining pacing attributes for a patient and include determining use of a beta blocker with intrinsic sympathomimetic activity (ISA) by the patient, receiving a current physiological input, and determining pacing attributes based on the determining use of the beta blocker with ISA and the current physiological input. They further include receiving a current physiological input, determining pacing attributes based on the current physiological input, causing a pacing device to output pacing outputs based on the pacing attributes, receiving an updated physiological input after causing the pacing device to output the pacing outputs, determining that a difference between the current physiological input and the updated physiological input does not meet a threshold difference, and generating an indication of a presence or use of a non-ISA beta blocker based on the difference not meeting the threshold difference.